Gilead Provides Update on Phase 3 ASCENT-07 Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. DSX
2. GNK
3. INTC
4. III
5. TTEC
6. DAL
7. AWK
8. SPCX
9. ABCB
10. WKC

Go back to Gilead Provides Update on Phase 3 ASCENT-07 Study
Gilead Sciences (NASDAQ: GILD) Delayed: 123.76 -1.69 (1.35%)
Previous Close $125.45    52 Week High $108.63 
Open $125.85    52 Week Low $71.39 
Day High $126.39    P/E 68.38 
Day Low $122.43    EPS $1.81 
Volume 14,348,344